23andMe: Current personal genomics market leader turned market loser?
Pivotal decision to not invest in new genetic technology to undercut 23andMe’s future position in the consumer genomics space
Pivotal decision to not invest in new genetic technology to undercut 23andMe’s future position in the consumer genomics space
An inside look at how Sephora uses technology in its stores to stay relevant in rapidly evolving times.
AI has become ubiquitous in our daily lives, influencing online search results to personal styling recommendations. Are we ready to let computers read our X-rays?
The commodification of healthcare data and its resulting losers
As the on-demand economy begins to disrupt healthcare, One Medical Group is best positioned to lead the booming market of on-demand primary care
With the rise of US smartphone adoption as well as chronic conditions, a myriad of digital health companies have started but never really gained traction. Omada has shown the health care community what a successful digital health intervention should look like: engaging, evidenced-based, and economical.
Who is Kayla and why does everyone want to “do Kayla”?
810 Bn dollars. A lot of money, and the estimated spend by self-insured employers on company healthcare benefits in 2012. Healthcare is now one of the top three costs for these companies (1). Artemis is a start-up in NYC that […]
Poshly allows beauty brands to access consumers' personal information on beauty habits and tastes
IMS Health’s products and services were used by pharmaceutical companies to develop commercialization plans, more recently IMS Health has expanded their focus –going beyond analyzing sales trends to improving patient outcomes and effectiveness data.